This is the kind of scientific arrogance that undermines the credibility of science. It's not about prestige, it's about getting the knowledge out to the most relevant audience; those who understand and care about proteomics.
I think it's great that another clinical study validates the technology and it has been peer reviewed in a field-relevant journal. Clearly it works,.. a lot more than can be said about other biotechs at this market cap.
If I recall, this latest study was initiated in support of ongoing licensing negotiations. The excellent results surely brings a significant license agreement a step closer.
PIQ Price at posting:
21.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)